SEARCH RESULTS FOR: "Tag: DEPO"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2017(7)
2016(10)
2015(9)
CATEGORIES
Analyst Downgrades(2)
Analyst Update(6)
Analyst Upgrades(1)
Buzz Stocks(8)
By the Numbers(1)
Earnings Preview(1)
Ezines(1)
General(1)
Indicator of the Week(1)
Intraday Option Activity(1)
Investor Sentiment(1)
Midday Market Check(2)
Opening View(1)
Stock Market News(1)
Stocks On the Move(2)

12/5/2017 9:24 AM
Shares of Depomed Inc (NASDAQ:DEPO) are almost 12% higher in electronic trading, after the biotech said it is licensing the sales rights to its opioid pain drugs, Nucynta IR and Nucynta ER, to Colle...
8/8/2017 9:20 AM
Analysts are weighing in on micro blogging site Twitter Inc (NYSE:TWTR), drug stock Depomed Inc (NASDAQ:DEPO), and hospital operator Tenet Healthcare Corp (NYSE:THC). Here's a quick roundup of today...
8/4/2017 10:54 AM
The healthcare sector is one group that'll see plenty of attention next week, given the earnings schedule. Two drug companies that will be releasing quarterly reports are Depomed Inc (NASDAQ:DEPO) an...
3/29/2017 9:17 AM
Stock futures are signaling a soft start to the day, as Brexit negotiations get underway across the pond. Among specific stocks in focus are drugmakers Depomed Inc (NASDAQ:DEPO), Sonoma Pharmaceutica...
2/22/2017 11:43 AM
Stocks are fighting to hold onto gains this morning. Among specific equities in focus are healthcare stocks Depomed Inc (NASDAQ:DEPO), Argos Therapeutics Inc (NASDAQ:ARGS), and Microbot Medical Inc ...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center